Clinical Trial Update: Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating Vorinostat, Temozolomide, or Bevacizumab with radiation, followed by Bevacizumab and Temozolomide, in young patients with newly diagn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Stem Glioma
• Cerebral Astrocytoma
• Childhood Cerebellar Anaplastic Astrocytoma
• Childhood Cerebral Anaplastic Astrocytoma
• Childhood Spinal Cord Neoplasm

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)
• Vorinostat (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain Stem Glioma, Cerebral Astrocytoma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-06-22